Using the cultured cells used in this experiment and described in the introduction, how would you approach determining the potency of an agonist to the D2 receptor? Receptor binding can be assessed in a number of ways. One ofthe simplest is to use a ligand that is radio labelled, usually with³H or ¹4C; receptor binding can be calculated as a function of theamount of radioactivity associated with receptors in a givensample. With increasing concentrations of a radioligand, theamount that binds to cells increases up to a point, then plateaus.This represents total binding and includes binding of theradioligand to receptors, together with other parts of the cell (e.g.membrane phospholipids). In order to determine the level ofspecific binding to receptors the assay must be repeated in thepresence of excess unlabelled ligand (either the same ligand or asuitable competitor). Under these conditions, the radioligandcannot bind the high-affinity receptor sites since these have beenoccupied by the unlabelled ligand; the radioligands thereforebind to non-receptor sites in a non-saturable fashion. This isnon-specific binding. The specific binding of radioligand toreceptor can be calculated as the difference between total andnon-specific binding.In this data interpretation exercise, you are presented with realdata from a ligand binding experiment performed at theUniversity of Kent. This experiment assessed the reversiblebinding to the D₂ dopamine receptor expressed in the membranesof Chinese Hamster Ovary (CHO) cells. This will involve using[³H]-spiperone, a dopamine receptor antagonist, in the presenceof (+)-butaclamol (for the analysis of non-specific binding) and(-)- butaclamol (for the analysis of total binding). Data analysiswill be carried out to generate binding curves in order todetermine the K₂ and B value of the dopamine receptormaxexpressed in this cell line. IntroductionHormone receptors bind ligands with high affinity using ionic,van der Waals and hydrophobic interactions. This binding canbe represented as a simple reversible reaction.Where R =receptor, H free hormone and RHreceptorhormone complex. Therefore the dissociation constant of thereceptor-ligand complex, K, can be defined as follows:Fractional ligand binding [RH]/R+][RH]R₁0.5R+Hwhere the affinity of the receptor for its ligand is inverselyproportional to the K, value. When written in the form of theMichaelis Menten equation:Total binding.=KDRHK₁ = [R][H][RH]Where R = total number of free [R] and bound [RH] receptors,and the K₂ value equals the concentration of ligand required tooccupy half of the total number of available receptors:Dose-occupancy curveSpecific binding.=Non-specific bindingLigand concentration11 +K₂/[H]Figure 1. Typical dose-response curves of a receptor bindingassay

When increasing amounts of the labelled ligand are added to the cells, the amount of binding will…

Answered: Using the cultured cells used in this…

Using the cultured cells used in this experiment and described in the introduction, how would you approach determining the potency of an agonist to the D2 receptor?

Biochemistry

9th Edition

ISBN:9781319114671

Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Publisher:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Chapter1: Biochemistry: An Evolving Science

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

Briefly explain the difference between a receptor antagonist and a receptor inverse agonist. Describe both the resulting receptor conformation as well as the signal transduction.
In the discussion section the authors wrote “In this study, we observed that different paradigms of tES application could ameliorate motor function impairments in ICH induced by collagenase administration into the striatum of rats.” a. Is the information in this quote about afferent of efferent? b.By what word or words do you know that your answer to the question is correct? c. Why did you choose this word or words as an answer to the question?
From the Hill Plot below, the of the first binding event for the receptor-ligand system under study is: Q1 4nM Ο 10 μΜ -2 nM 2 nM Calculate the Hill Coefficient from the receptor-ligand binding data below: Q2 4 100 2 3 (0-1) 60 log 10 8 6 4 2 0 -2 -4 -6 -6 -4 -2 0 2 4 log [L] (nM) 6 8 10
Briefly explain the role of acetlycholinesterase inhibitors in impulse transmission process
Why are the catecholamines listed for a variety of receptor pathways?
explain what does hisatmine and adetycholine mimic. within smooth muscle receptors. what do they bind and what do they activate.
Suppose that you measured binding to the isolated EGF receptor of EGFat various concentrations. Would you expect the binding curve to be hyperbolic? Explain your answer.
The top panel (a) of this figure shows the graded potential change (far right, upper, electrical trace) that results from ligand binding to the ligand gated Na+ channel. The bottom panel of this figure (b) shows a graded potential change (far right, lower, electrical trace) that results from ligand binding to a ligand gated Cl- channel. From this trace you know (Vm = -70 mV) 1. ECl- is -70 mV 2. ECl- is more negative than -70 mV (i.e., -80 mV) 3. ECl- is more positive than -70 mV (i.e., -60 mV)
What are the receptors involved in long term alcohol use binding and between GABBA agonist receptor and NDMA antagonist receptor, what will be the long term receptor changes?
A GRK inhibitor would have what effect on GPCR inactivation in the presence of a GPCR agonist? (a) it would decrease it; (b) it would maintain the same rate of inactivation; (c) it would increase it.
Which of the following mechanisms of action could the drug from the above question potentially have to cause the described effects in male rats (so disruption of male sexual behavior when given prenatally but not when given in adulthood)? Group of answer choices Estrogen receptor antagonist or aromatase inhibitor Testosterone receptor antagonist Estrogen receptor antagonist Aromatase inhibitor
Based on your knowledge of signal transduction downstream of G-protein coupled receptors, describe the pathway by which sulcatone may cause an action potential?